Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Travel & leisure stocks outperform following full FDA vaccine approval

Published 24/08/2021, 11:48
Updated 24/08/2021, 11:51
© Reuters.

By Samuel Indyk

Investing.com – Travel and leisure stocks were outperforming in the UK on Tuesday after the US Food and Drug Administration (FDA) fully approved Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) Covid vaccination. It is the first jab to be fully licenced after previously receiving Emergency Use Authorization (EUA).

Full approval

Approval of the vaccine is expected to lead to greater take-up amongst US citizens. A recent survey by the Kaiser Family Foundation found that 31% of unvaccinated people said they were more likely to get vaccinated if the FDA gave full approval to vaccines, according to Bloomberg News.

Separately, many companies and organisations are expected to introduce vaccine mandates. The US military set this off, saying they would require all 1.3 million active-duty troops to get vaccinated.

Travel & Leisure shares jump

Shares in Travel & Leisure stocks jumped following the news. Cineworld (LON:CINE) - which has operations in the US - saw its shares rally as greater vaccination take up in the US may encourage cinemagoers to return to screens. Earlier this month, Cineworld had said there could be “no certainty” over its recovery from the pandemic in the short-term as revenue declined 59% in the first half of the year.

Airlines were also strong, with EasyJet (LON:EZJ), Wizz Air (LON:WIZZ), Ryanair (LON:RYA), and IAG (LON:ICAG) all trading higher. Carnival (NYSE:CCL) (LON:CCL), which is dual listed in the UK and US, also reacted positively to the news. Its US listed shares closed higher by just shy of 4% on Monday, while its London listing jumped over 3% in early trade on Tuesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.